Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).

Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).

Item
http://www.wikidata.org/entity/Q33471448
African horse sickness: The potential for an outbreak in disease-free regions and current disease control and elimination techniques.Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge.A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -/- mouse model.Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus.Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus.Real time RT-PCR assays for detection and typing of African horse sickness virusDevelopment of a Microsphere-based Immunoassay for Serological Detection of African Horse Sickness Virus and Comparison with Other Diagnostic Techniques.Generation and epitope mapping of a sub-group cross-reactive anti-respiratory syncytial virus G glycoprotein monoclonal antibody which is protective in vivo.The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model
P2860

Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).

Item
http://www.wikidata.org/entity/Q33471448
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Induction of antibody response ...... odified vaccinia Ankara (MVA).
@ast
Induction of antibody response ...... odified vaccinia Ankara (MVA).
@en
type
label
Induction of antibody response ...... odified vaccinia Ankara (MVA).
@ast
Induction of antibody response ...... odified vaccinia Ankara (MVA).
@en
prefLabel
Induction of antibody response ...... odified vaccinia Ankara (MVA).
@ast
Induction of antibody response ...... odified vaccinia Ankara (MVA).
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Induction of antibody response ...... odified vaccinia Ankara (MVA).
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0005997
P407
P433
P478
P50
P577
P5875
P698
P932